MedPath

A CLINICAL TRIAL TO STUDY THE EFFECT OF THE DRUG SARABENDHIRAR SIDDHA MARUTHUVA SUDAR CHOORANAM IN PATIENTS HAVING DIABETES MELLITUS-TYPE II

Phase 2
Not yet recruiting
Conditions
Type 2 diabetes mellitus with unspecified complications,
Registration Number
CTRI/2018/12/016569
Lead Sponsor
Government Siddha Medical college
Brief Summary

This is a single Non-randomized open clinical trial to study the safety and efficacy of Siddha trial drug **SARABENDHIRAR SIDDHA MARUTHUVA SUDAR CHOORANAM.**The trial drug is given 4 grams twice a day for 90 days. Clinical trial is conducted after conducting Preclinical toxicity study. The trial drug SARABENDHIRAR SIDDHA MARUTHUVA SUDAR CHOORANAM is mentioned in Sarabendhirar Siddha maruthuva sudar. During the trial all the study related data will be recorded and documented. After the completion of trial all the data will be analysed statistically.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Age between 30 to 60 years Newly identified Type II Diabetic cases within 6 months Blood glucose (F)-126 mg/dl to 140 mg/dl Blood glucose (PP)-180 mg/dl to 280 mg/dl HBA1C-6.5% to 8% Polyuria Polyphagia Polydipsia Nocturia.

Exclusion Criteria

Age below 30 and above 60 years Insulin dependent Diabetes Mellitus Cardiovascular diseases K/C/O Diabetic Nephropathy K/C/O Diabetic Neuropathy K/C/O Diabetic Retinopathy Pregnant women and lactating mothers T.B affected individuals will be excluded clinically or based on available medical reports.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Outcome is mainly assessed by reduction in clinical symptoms, Blood sugar level and HbA1C level (Minimum 10 to 20%)90 Days
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Arignar Anna Government Hospital for Indian Medicine

🇮🇳

Chennai, TAMIL NADU, India

Arignar Anna Government Hospital for Indian Medicine
🇮🇳Chennai, TAMIL NADU, India
Dr Dhivyalakshmi K
Principal investigator
7094884605
kjdhivya24@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.